Literature DB >> 549188

Colitis induced by Clostridium difficile.

J G Bartlett, T Chang, N S Taylor, A B Onderdonk.   

Abstract

Clostridium difficile has been implicated as the major cause of antibiotic-associated pseudomembranous colitis. The current laboratory diagnostic test of choice is a tissue culture assay that demonstrates the presence of a cytopathic toxin neutralized by antitoxin to Clostridium sordellii. This toxin was found in stools from 42 of 43 patients with antibiotic-associated pseudomembranous colitis and in stools from 12 of 78 patients with antibiotic-associated diarrhea. Specimens from patients with gastrointestinal conditions unrelated to administration of antibiotics and those from healthy controls were uniformly negative. Neutralization of toxin by antitoxin to C. sordellii appears to represent antigenic cross-reactivity, since broth cultures of C. difficile also contain a cytopathic toxin neutralized by this antitoxin. Strains of C. difficile are susceptible to vancomycin, and the initial clinical experience with oral administration of this agent shows promising results.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 549188     DOI: 10.1093/clinids/1.2.370

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  30 in total

Review 1.  Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.

Authors:  Perry Hookman; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2007-02-16       Impact factor: 3.199

2.  Effect of yogurt on clindamycin-induced Clostridium difficile colitis in hamsters.

Authors:  C M Kotz; L R Peterson; J A Moody; D A Savaiano; M D Levitt
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

3.  Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius.

Authors:  A M Jokipii; L Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

Review 4.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studies.

Authors:  J M Libby; T D Wilkins
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Diarrheal disease and DRGs.

Authors:  Peter H Gilligan
Journal:  Clin Microbiol Newsl       Date:  2004-01-22

7.  Role of Clostridium difficile and Campylobacter jejuni in relapses of inflammatory bowel disease.

Authors:  L Gurian; K Klein; T T Ward
Journal:  West J Med       Date:  1983-03

8.  Survey of the extrachromosomal gene pool of Clostridium difficile.

Authors:  L L Muldrow; E R Archibold; O L Nunez-Montiel; R J Sheehy
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

Review 9.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  Relative frequency of Clostridium difficile in patients with diarrheal disease.

Authors:  P H Gilligan; L R McCarthy; V M Genta
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.